Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06141941 · ClinicalTrials.gov registry record · NA
Does the Use of Continuous Glucose Monitoring (CGM) in the Immediate Postpartum Period in Women With Pregestational Diabetes Admitted to the Hospital Decrease Hypoglycemic Episodes
A NA study of Pre-Gestational Diabetes, sponsored by Andrea L. Greiner.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06141941: Recruiting NA study of Pre-Gestational Diabetes, sponsored by Andrea L. Greiner.
NCT06141941 is a NA study of Pre-Gestational Diabetes that is actively recruiting participants, run by Andrea L. Greiner. The registered enrollment target is 40 participants, below the 126-participant average among 3 other Pre-Gestational Diabetes trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06141941, a NA study of Pre-Gestational Diabetes, is actively recruiting participants, sponsored by Andrea L. Greiner.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine whether continuous glucose monitoring in patients hospitalized in the immediate postpartum period is more effective than traditional point of care glucose testing in identifying patients with hypoglycemia.
Primary Outcome
glucose values
Conditions Studied
Interventions
- DEVICE CGM
Study Locations (1)
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2024-04 |
| Phase | NA |
What NCT06141941 shows while recruiting
NCT06141941 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 126-participant average among 3 other Pre-Gestational Diabetes trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Pre-Gestational Diabetes appearing as the primary indexed condition, and to 1 intervention - of which CGM is the first listed.
NCT06141941 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT06141941 about?
NCT06141941 is a clinical study titled "Does the Use of Continuous Glucose Monitoring (CGM) in the Immediate Postpartum Period in Women With Pregestational Diabetes Admitted to the Hospital Decrease Hypoglycemic Episodes". This study will examine whether continuous glucose monitoring in patients hospitalized in the immediate postpartum period is more effective than traditional point of care glucose testing in identifying patients with hypoglycemia.
What is the current status of trial NCT06141941?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2021-06-01. Estimated completion is 2024-04.
What conditions does trial NCT06141941 study?
This clinical trial studies the following conditions: Pre-Gestational Diabetes.
What interventions are being tested in trial NCT06141941?
The interventions under investigation include: CGM (DEVICE).
Who is sponsoring clinical trial NCT06141941?
This trial is sponsored by Andrea L. Greiner, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06141941 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pre-Gestational Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
RECRUITING · NA
-
Automated Insulin for Management of Intrapartum Glycemia
RECRUITING · NA
-
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI